130 related articles for article (PubMed ID: 7686049)
1. [Interstitial HDR afterloading therapy with flexible catheters].
Warszawski N; Bratengeier K; Bohndorf W
Aktuelle Radiol; 1993 May; 3(3):177-81. PubMed ID: 7686049
[TBL] [Abstract][Full Text] [Related]
2. Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy.
Strnad V
Strahlenther Onkol; 2004 Nov; 180(11):710-7. PubMed ID: 15549189
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients.
Nose T; Koizumi M; Nishiyama K
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):983-91. PubMed ID: 15234031
[TBL] [Abstract][Full Text] [Related]
4. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
[TBL] [Abstract][Full Text] [Related]
5. Head and neck brachytherapy.
Mazeron JJ; Noël G; Simon JM
Semin Radiat Oncol; 2002 Jan; 12(1):95-108. PubMed ID: 11813154
[TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
7. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate?
Nose T; Peiffert D; Lapeyre M; Hoffstetter S; Koizumi M; Nishiyama K
Strahlenther Onkol; 2004 Dec; 180(12):776-82. PubMed ID: 15592697
[TBL] [Abstract][Full Text] [Related]
8. [Brachytherapy boost irradiation in the treatment of high risk, localised prostate cancer. Initial national experience in Hungary].
Agoston P; Major T; Somogyi A; Szûcs M; Danczig A; Lövey J; Polgár C; Fodor J; Németh G; Kásler M
Magy Onkol; 2004; 48(1):81-8. PubMed ID: 15105901
[TBL] [Abstract][Full Text] [Related]
9. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
10. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
11. Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: a retrospective study.
Kubo T; Sugita T; Shimose S; Matsuo T; Hirao K; Kimura H; Kenjo M; Ochi M
BMC Cancer; 2005 Jul; 5():79. PubMed ID: 16026629
[TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
13. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R
Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167
[TBL] [Abstract][Full Text] [Related]
14. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
15. [The results of primary HDR-afterloading brachytherapy in corpus carcinoma].
Knocke TH; Kucera H; Weidinger B; Höller W; Pötter R
Strahlenther Onkol; 1995 Apr; 171(4):195-201. PubMed ID: 7740406
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
17. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
[TBL] [Abstract][Full Text] [Related]
18. Curative interstitial brachytherapy for early stage carcinoma lip.
Jha AK; Prasiko G; Mod M; Srivastava R; Chaurasia PP
JNMA J Nepal Med Assoc; 2006; 45(162):252-7. PubMed ID: 17189971
[TBL] [Abstract][Full Text] [Related]
19. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy.
Chen J; Pappas L; Moeller JH; Rankin J; Sharma PK; Bentz BG; Fang LC; Hayes JK; Shrieve DC; Hitchcock YJ
Head Neck; 2007 Apr; 29(4):362-9. PubMed ID: 17163468
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
